Acquisition

A new investment in a Mid-Atlantic firm highlights how private capital is flowing into the multi-trillion-dollar challenge of fixing the nation's water systems.

Private equity firm Thurston Group launches Sensorium Clinical Research, a new network aiming to unify top trial sites and streamline medical innovation.

With a new strategic investor and a star executive on its board, Apreo Health is poised to advance its breakthrough BREATHE Airway Scaffold for severe emphysema.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

As Quebecor prepares for its annual meeting, a look at its strong 2025 results, aggressive telecom expansion, and strategy to challenge Canada's giants.

McDonald's enters the stadium naming game with a massive community pledge for Chicago, but not all residents are cheering for the new riverfront project.

The uranium giant posts a net profit after its major acquisition, but a significant cash outflow has investors weighing long-term growth against short-term risks.

HireQuest's persistent $105M cash offer for TrueBlue's on-demand arm puts the staffing giant at a crossroads, fueling speculation of a sector shake-up.

Industrial tech giant Fortive is restructuring its balance sheet, locking in long-term capital to refinance old debt and fund future growth initiatives.

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

Andersen Group reports a 15.7% revenue jump, but IPO-related costs mask strong operational performance as the firm pursues aggressive global expansion.

After two rejections and a dramatic financial restructuring, Atara Biotherapeutics has a clear path to resubmit its key cancer therapy to the FDA.

Vistage expands its global CEO advisory dominance by acquiring its longtime Canadian licensee, TEC Canada, integrating 1,600 members into its network.

Palladium Equity Partners acquires a majority stake in DME Express, signaling a major push for growth in the critical, yet scrutinized, hospice care market.

Graitec achieves Bluebeam's top partner tier, a calculated move strengthening its North American dominance after key acquisitions and signaling market shifts.

The acquisition of ABCP conduit Lime Funding, backed by SuMi TRUST and GreensLedge, signals South Street Securities' bold expansion into short-term debt markets.

Daimler-backed Torc Robotics hires ex-Alphabet exec Tobias Wessels, signaling a major push to get its Level 4 autonomous trucks on the road by 2027.

A new report reveals AI-powered answers are the new top content channel, forcing B2B marketers to prioritize credibility over clicks for visibility and leads.

After a $40M sale and a massive stock buyback, DTST is pivoting to AI continuity, a niche but critical market for regulated industries. Is it a masterstroke?

Lightpath is building a 392-mile fiber network linking two of the world's fastest-growing data hubs, a major bet on the future of AI infrastructure.